Informing Spectroscopists for Over 40 Years

SCIEX announces the first FDA-cleared Vitamin D assay kit for mass spectrometry

1 June 2017 | Product
by Ian Michael

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX has announced today the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit. The Vitamin D 200M Assay, for use with the SCIEX Topaz System. The Topaz System is an integrated LC-MS platform controlled by ClearCore MD, the new software designed specifically for use in clinical labs. While individually quantitating D2 and D3 isomers, the Topaz System running the Vitamin D 200M Assay Kit, also automatically differentiates between D3 epimers, providing the specificity to deliver highly accurate diagnostic results in a single analysis.

The Vitamin D 200M Assay for the Topaz System is intended for in vitro diagnostic use in the quantitative determination of total 25-hydroxyvitamin D (25-OH-D) through the measurement of 25-hydroxyvitamin D3 (25-OH-D3) and 25-hydroxyvitamin D2 (25-OH-D2) in human serum using LC-MS/MS technology by a trained laboratory professional in a clinical laboratory.

Currently, the SCIEX Vitamin D 200M Assay Kit is only available in the United States.

Request Information about this Product

By submitting this form you agree that we may pass this information to the company who you are enquiring about.